Enabling Diagnostics & R&D
At rHEALTH®, we are excited to share our developments with the scientific and medical communities. These support our efforts to bring powerful diagnostics to all.
At rHEALTH®, we are excited to share our developments with the scientific and medical communities. These support our efforts to bring powerful diagnostics to all.
Facilitating early access research, diagnostics, and partnerships
Introducing a powerful biomedical analyzer for advancing your understanding of human health and biology. The device features maximum portability, ease-of-use, with multiple lasers and high-sensitivity photon counting detectors. It analyzes tiny volumes for precious samples.
NASA will launch the device to space the end of 2021 to assess its performance in zero gravity and to mitigate the risks of space radiation, circadian disturbances, bone loss, and cardiovascular effects as humans have ambitious of traveling to Mars.
The rHEALTH ONE counts viruses, including SARS-CoV-2. Currently virus counting requires qPCR. The rHEALTH ONE leverages its single molecule sensitivity to detect individual virus genomes passing through the detector for accurate viral counts in laboratory setting. Absolute volumetric counts are obtained using the rHEALTH sample consumable.
The rHEALTH utilizes dual lasers to perform cell counts and flow cytometry. Up to five parameters are available on the device (3 FL, SSC, FSC). These allow distinguishing different cell types and absolute volumetric cell counts.
The analyzer utilizes 5-10 uL of sample, allowing assays to be scaled down dramatically. Mouse samples, fingerstick blood, and frozen specimen aliquots are all suitable for analysis.
High-sensitivity (pg/mL) immunoassays and enzyme activity assays. The rHEALTH ONE allows for sensitivity measurements of protein biomarkers. Assay formats include sandwich and competitive immunoassays. Enzymatic methods are also compatible with the analyzer.
Cell-free DNA, gene expression analysis.
The rHEALTH ONE, when used with nanostrips and our assay kits provide massive multiplexing for biomarkers.
Remaining true to our mission of making our capabilities more accessible, we are pleased to announce that we have established a Center for Excellence, which will allows us to readily collaborate with the broader scientific, medical, and patient community. Together, we can advance our scientific and medical understanding of diseases.
*rHEALTH devices are limited by FDA regulation for research or investigational purposes only.